CMP: INR110 TP: INR130(+17%) Buy Cement division set for a better 2HFY18

Similar documents
Domestic air passengers increase 16.9% in November

CMP: INR270 TP: INR335(+24%) Buy Takes price hike disguised as evacuation charges

Expect capacity-led rerating; maintain Buy

CMP: INR80 TP: INR106(+32%) Buy MIB approves merger of VD2H

CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India

Lupin. CMP: INR861 TP: INR1,000(+16%) Buy Goa and Indore plant receives Warning Letter

Domestic shortage driving e-auction prices

Focus on premium segment and bridging product gaps

Idea Cellular. CMP: INR105 TP: INR120 (+15%) Buy Board approves raising INR32.5b via preferential issue

CMP: INR120 TP: INR140(+16%) Buy

CMP: INR64 TP: INR65 (+1%) Neutral Going retail

CMP: INR228 TP: INR275 (+20%) Buy Firm utilization continues

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

CMP: INR759 TP: INR910 (+20%) Upgrade to Buy Ad recovery on the cards

Bata India. CMP: INR415 TP: INR483 (+16%) Upgrade to Buy Aggressive, focused strategy to drive growth. Upgrading to Buy

CMP: INR945 TP: INR1,196 (+26%) Buy

Banking on innovation to drive growth

CMP: INR688 TP: INR1,050(+53%) Buy Opportunity in adversity?

CMP: INR2,623 TP: INR2,875 (+10%) Neutral

CMP: INR145 TP: INR196 (+33%) Buy Expect orders to spurt in FY19

Appoints CapGemini s Salil Parekh as CEO and MD. Potential positives

CMP: INR656 TP: INR780(+19%) Buy Solutions in sight

CMP: INR400 TP: INR470(+18%) Buy

CMP: INR840 TP: INR941 (+12%) Neutral TRAI boost to RJio; increasing target price

CMP: INR949 TP: INR1,140 (+20%) Buy

Financial integrity intact; FDA resolution the key

CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification

CMP: INR272 TP: INR361(+33%) Buy Production ramp-up encouraging

CMP: INR475 TP: INR609 (+28%) Buy

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

Result Update. Nilkamal Limited CMP: INR1675 TP: INR2,184(+30%) Quarterly Standalone Performance (INR mn)

CMP: INR734 TP: INR764 (+4%) Neutral

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block

CMP: INR532 TP: INR675(+27%) Buy

CMP: INR158 TP: INR195 (+24%) Buy Lowering crude oil price estimates

CMP: INR113 TP: INR180(+59%) Buy Some pricing pressure, but fundamentals are strong

Voltas-Beko product line to be launched in 2HCY18. We recently met management of Voltas (VOLT). Key takeaways:

JSW Energy. CMP: INR59 TP: INR84 (+42%) Buy Valuations heavily discounting merchant capacities

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

CMP: INR576 TP: INR590 (+2%) Neutral Advancement and PMLA affect 2QFY18 sales

CMP: INR678 TP: INR780 (+15%) Buy

April 2017: Off-take growth remains strong

CMP: INR681 TP: INR815(+20%) Buy

Idea Cellular. CMP: INR59 TP: INR75(+27%) Buy Near-term headwinds persist

ABB India to remain a key sourcing hub

CMP: INR158 TP: INR199 (+26%) Buy NTPC FY16 annual report analysis

Hindustan Zinc. 30 April QFY18 Results Update Sector: Metals. Estimate change TP change Rating change

Dispatches impacted by destocking at power plants

CMP: INR1,952 TP: INR2,246(+15%)

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

CMP: INR164 TP: INR198(+21%) Buy Project commissioning augurs well for capitalization

Sanjay Jain Pavas Pethia

A win-win combination

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Mr Nilesh Gupta MD. Lupin. Prepping for next wave of growth. Takeaways from CEO track

Birla Corporation. CMP: INR484 TP: INR590 (+22%) Buy

CMP: INR388 TP: INR465(+20%) Buy

Larsen & Toubro. CMP: INR1,400 TP: INR1,690 (+21%) Divests E&A business to Schneider Electric for INR140b

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

CMP: INR587 TP: INR705 (+21%) Upgrade to Buy

Castrol India. CMP: INR407 TP: INR474 (+16%) Neutral

Ashok Leyland. CMP: INR126 TP: INR159 (+26%) Buy M&HCV axle load proposed to be increased up to 25% Is it precursor to stricter norms on overloading?

Ashok Leyland. CMP: INR145 TP: INR179 (+23%) Buy Positive CV demand outlook for FY19 and FY20

CMP: INR826 TP: INR810 (-2%) Neutral

1 August QFY18 Results Update Sector: Metals JSW Steel. Estimate change TP change Rating change. Quarterly Performance (Consolidated) INR m

CMP: INR907 TP: INR1,150(+24%) Buy

Jinesh Gandhi Sandipan Pal

V-Guard Industries. CMP: INR1,591 TP: INR1,625 (+2%) Neutral

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Exhibit 5: Per ton analysis (incl Windmills, INR m)

CMP: INR346 TP: INR411(+19%) Buy Opportunity in the blip

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Hardick Bora

Decent performance by the sector in a tough quarter

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

CPCB-2: Important long-term driver

Attractive valuations could be illusory

Visaka Industries Ltd

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

Earnings dilution transitory; maintain Buy

CMP: INR224 TP: INR268 (+20%) Buy

Spotlight The Idea Junction

Change EPS. (Rs) FY

Cross service charges at INR m/quarter

India Cements. CMP: INR107 TP: INR113 (+6%) Neutral

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

CMP: INR293 TP: INR300(+2%) Neutral To sell hosted datacenter services business

To voluntarily stop supplies to US

CMP: INR1,177 TP: INR1,291(+10%) Temporary hiccups; long-term growth visible

CMP: INR865 TP: INR1,015 (+17%) Buy Building blocks for strong growth

CMP: INR540 TP: INR650 (+20%) BUY

CMP: INR1,047 TP: INR1,300 (+24%) Much-awaited SEBI guidelines on options finally out

Niket Shah

Gujarat Pipavav Port. CMP: INR162 TP: INR212 (31%) Buy

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Utilities. Seven things we learned at a conference on power distribution

Cummins India Ltd Bloomberg Code: KKC IN

CMP: INR350 TP: INR375 Downgrade to Neutral

Hold Target Price: Rs 574

Idea Cellular. CMP: INR159 TP: INR200 Buy

Transcription:

BSE SENSEX S&P CNX 32,870 10,128 4 December 2017 Update Sector: Cement Prism Cement CMP: INR110 TP: INR130(+17%) Buy Cement division set for a better 2HFY18 TBK segment to see profitability improvement led by better product mix Stock Info Bloomberg PRSC IN Equity Shares (m) 503.4 52-Wk Range INR 130 / 72 1, 6, 12 Rel. Per % -6/-10/-1 M.Cap. (INR b) 57.1 M.Cap. (USD b) 0.9 Avg Val, INRm 39.0 Free float (%) 25.1 Financials Snapshot (INR b) Y/E Mar 2018E 2019E 2020E Net Sales 52 55 56 EBITDA 4 5 7 PAT 1 3 3 EPS (INR) 3 5 7 Gr. (%) 905 81 33 BV/Sh. INR 21 26 32 RoE (%) 13.7 21.3 23.1 RoCE (%) 10.6 14.0 17.5 P/E (x) 41.3 22.8 17.2 P/BV (x) 5.4 4.4 3.6 Shareholding pattern (%) As On Sep-17 Jun-17 Sep-16 Promoter 74.9 74.9 74.9 DII 9.4 9.3 6.5 FII 6.4 6.5 9.6 Others 9.4 9.3 9.0 FII Includes depository receipts Stock Performance (1-year) Prism Cement Sensex - Rebased 130 115 100 85 70 Dec-16 Mar-17 Jun-17 Aug-17 Nov-17 We recently hosted Prism Cement (PRSC) at our Midcap Conference. Cement demand for the company is likely to grow 5% YoY in 2HFY18, led by resolution of the sand mining issue in UP, a favorable base of 2HFY18 (was impacted by demonetization) and strong growth from the underlying markets of UP/MP. Improved pricing in the central market driven by higher consolidation, limited supply addition and strong demand will result in a margins improvement for the cement division in 2HFY18/FY19. TBK segment should see a margins improvement in 2HFY18/FY19, led by its higher utilization, product mix improvement and new product launches. Led by a favorable base and a positive business outlook in both cement and TBK, we expect EBITDA CAGR of 29% over FY17-20. Cement demand to inch up in 2HFY18/FY19 PRSC s volumes fell ~3% YoY in 1HFY18 due to the ramp-up of JPA s assets and demand destruction in the underlying markets due to the sand mining ban in UP/Bihar (together constitute ~72% of its overall volumes). Our channel checks suggest that the sand mining ban issue in UP has been resolved, which bodes well for demand in the central market. Additionally, strong demand from the central region, led by the affordable housing program in MP and the infrastructure projects in UP, should result in significant increase in off take. Hence, we expect cement demand for PRSC to grow ~5% YoY in 2HFY18 v/s a decline of 3% YoY in 1HFY18. Margin improvement led by improved pricing We expect the cement segment s profitability to improve in 2HFY18/FY19 (v/s 1HFY18), led by improved pricing on the back of consolidation, limited supply addition and improved utilization in the central region. However, we expect some of these benefits to be negatively impacted by cost push in form of higher power & fuel cost (due to an increase in petcoke prices and coal prices). Better focus and product mix to drive profits for TBK TBK segment (standalone) has seen a sharp reduction in EBIT losses in 2QFY18 (from INR230m to INR50m), led by volume growth (v/s volume decline in previous quarters), a better product mix, and new product launches. We expect losses in TBK (standalone) to reduce further in 2HFY18 on improved volume growth and positive operating leverage. Abhishek Ghosh Research analyst (Abhishek.Ghosh@MotilalOswal.com); +91 22 3982 5436 Pradnya Ganar Research analyst (Pradnya.Ganar@motilaloswal.com); +91 22 3980 4322 Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on www.motilaloswal.com/institutional-equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.

Strong earnings CAGR over FY17-20E PRSC is likely to generate strong earnings CAGR over FY17-20, led by i) an improvement in cement profitability on the back of pricing improvement and positive operating leverage, and ii) a turnaround of TBK (standalone) due to positive operating leverage, a better product mix and an improved sales focus. Hence, we expect margin improvement of 5.6pp over FY17-20, which should drive EBITDA CAGR of 29%. Valuation view Our SOTP value for PRSC is INR130/share (EV of USD110/ton, 5x FY20E RMC EBITDA and 10x FY20E TBK EBITDA). PRSC is a pure play on a recovery in central India, which is likely to see strong improvement in profitability, driven by higher consolidation in the region over the last 12-18 months. Additionally, the region is likely to see no meaningful capacity addition over the next 18-24 months. However, there could be some pricing volatility over the next 2-3 quarters due to the ramp-up of JPA s assets. However, the key monitorable would be a turnaround in TBK profitability, which has also seen a marked improvement in 2QFY18. Maintain Buy. 4 December 2017 2

Cement demand to look up in 2HFY18/FY19 PRSC serves the markets of UP, MP and Bihar. Demand in these markets had been subdued over the last six months due to the sand mining ban. As a result, PRSC has seen volumes decline by ~3% YoY in 1HFY18 due to the ramp-up of JPA s assets and demand destruction in the underlying markets due to the sand mining ban in UP/Bihar (which constitute ~72% of its overall volumes). Our channel checks suggest that the issue pertaining to the sand mining ban in state of UP has been resolved, which should bode well for demand in the central market. Infrastructure projects in UP should drive demand in the region. The government s Pradhan Mantri Awaas Yojana (Gramin) (PMAY (G)) program focuses on building 10m houses in the rural areas. States of Bihar, Uttar Pradesh and Madhya Pradesh contribute ~40% of the rural target of 10m houses. Exhibit 1: Bihar, Uttar Pradesh and Madhya Pradesh contribute ~40% of rural target Others, 24% Bihar, 17% Chhattisgarh, 6% Rajasthan, 7% Odisha, 11% West Bengal, 12% Uttar Pradesh, 12% Madhya Pradesh, 12% Source: Ministry of Rural Development Strong demand led by the affordable housing program in MP and the infrastructure projects in UP should result in sustainably strong demand from the region. Hence, we expect cement demand for PRSC to grow at ~5% YoY in 2HFY18, as against a decline of 3% YoY in 1HFY18. Exhibit 2: Cement demand for PRSC for 2HFY18 appears favorable 13 10 14 5 Volumes (mt) -12 4-6 -9 1.5 1.3 1.3 1.5 1.4 1.3 1.2 1.4 1.5 1.2 1.2 1.6 1.5 1.1 1.2 1.6 12-14 YoY Growth(%) 15-4 -3-3 5 5 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18E 4QFY18E Exhibit 3: Cement demand to grow at 5% for next 2-3 years for the company 5.22 4.76 5.10 5.63 5.29 5.21 5.47 5.74 6.02 FY12-9% FY13 Volumes (mt) 7% FY14 11% FY15-6% FY16-2% FY17 YoY Growth(%) 5% 5% 5% FY18E FY19E FY20E 4 December 2017 3

Exhibit 4: Utilization levels to improve for cement division Capacity (mt) Dispatch (mt) Utilization (%) 93 85 91 80 76 74 78 82 86 5.2 4.8 5.1 5.6 5.3 5.2 5.5 5.7 6.0 5.6 5.6 5.6 7.0 7.0 7.0 7.0 7.0 7.0 FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Source: Company, MOSL Margin improvement led by improved pricing We are fairly positive on the long-term prospects of the central market, given utilization improvement due to limited capacity addition. While JPA ramp-up by Ultratech might put some volume pressure in the short term, it should bode well for the players in the region over the medium-tolonger run, as JPA s premium pricing will result in an improved pricing environment. We expect profitability of the cement segment to improve in 2HFY18/FY19 v/s 1HFY18, led by improved pricing on the back of consolidation, limited supply addition and improved utilization. However, we expect some of the benefits of higher pricing to be negatively impacted by cost push in the form of higher power & fuel cost (due to an increase in petcoke and coal prices). Exhibit 5: EBITDA/t was impacted in 2QFY18 due to poor pricing EBITDA/ton (INR/t) Exhibit 6: Expect EBITDA/t to reach INR 964 by FY20 (INR/t) EBITDA/ton 732 313 209 544 451 216 429 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 539 624 213 215 745 514 335 458 492 235 465 460 540 589 828 964 FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Better focus and product mix to drive profits for TBK segment TBK segment had witnessed a market share loss in FY17, which resulted in a sharp decline in its EBITDA. However, we expect a recovery in the market share and an improvement in margins, going forward, for the following reasons: Increase in capacity utilization, especially in owned manufacturing plants, should lead to improved operating leverage. 4 December 2017 4

Prism Cement is focusing on expanding its product range and launching new products. It has started display centers in Guwahati, Kolkata and Chennai. The company is also revamping its sales team to generate demand through strong influencer connect. Various cost-management programs and initiatives have also been undertaken. TBK segment (standalone) has seen a sharp reduction in EBIT losses in 2QFY18 (from INR230m to INR50m), led by volume growth (v/s volume losses in previous quarters), a better product mix, and new product launches. We expect losses in TBK (standalone) to reduce further in 2HFY18 on improved volume growth and positive operating leverage. Exhibit 7: Display center in Chennai Exhibit 8: Display center in Chennai Strong earnings CAGR over FY17-FY20 PRSC is likely to generate strong earnings CAGR, led by: improvement in cement profitability on the back of pricing improvement and positive operating leverage Turnaround of TBK (standalone) due to positive operating leverage, better product mix and improved sales focus. Hence, we expect margin improvement of 5.6pp over FY17-20, which is likely to drive EBITDA CAGR of 29%. 4 December 2017 5

Exhibit 9: Margins to improve by 5.6pp over FY17-20 EBITDA (INR mn) EBITDA margins(%) 9.8 11.7 5.3 4.9 4.7 5.5 6.1 7.2 2.4 2,388 2,342 1,199 2,621 2,862 3,049 3,717 5,401 6,504 FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Valuation view Our SOTP value for PRSC is INR130/share (EV of USD110/ton, 5x FY20E RMC EBITDA and 10x FY20E TBK EBITDA). PRSC is a pure play on a recovery in central India, which is likely to see strong improvement in profitability, driven by higher consolidation in the region over the last 12-18 months. Additionally, the region is likely to see no meaningful capacity addition over the next 18-24 months. However, there could be some pricing volatility over the next 2-3 quarters due to the ramp-up of JPA s assets. However, the key monitorable would be a turnaround in TBK profitability, which has also seen a marked improvement in 2QFY18. Maintain Buy. 4 December 2017 6

Financials and Valuations Income Statement (Consolidated) (INR Million) Y/E March 2013 2014 2015 2016 2017 2018E 2019E 2020E Net Sales 47,427 49,443 55,718 51,684 49,607 51,984 54,953 55,506 Change (%) 5.8 4.3 12.7-7.2-4.0 4.8 5.7 1.0 Total Expenditure 45,085 48,244 53,098 48,822 46,558 48,267 49,552 49,002 % of Sales 95.1 97.6 95.3 94.5 93.9 92.8 90.2 88.3 EBITDA 2,342 1,199 2,621 2,862 3,049 3,717 5,401 6,504 Margin (%) 4.9 2.4 4.7 5.5 6.1 7.2 9.8 11.7 Depreciation 1,598 1,766 1,368 1,841 1,918 1,479 1,642 1,712 EBIT 744-567 1,252 1,021 1,131 2,238 3,759 4,792 Int. and Finance Charges 1,903 2,415 2,536 2,814 2,166 1,761 1,720 1,660 Other Income - Rec. 313 363 556 2,070 1,437 1,250 1,300 1,300 PBT bef. EO Exp. -846-2,619-729 277 402 1,726 3,339 4,432 EO Expense/(Income) -16-1,341-621 39-15 0 0 0 PBT after EO Exp. -830-1,278-108 237 417 1,726 3,339 4,432 Current Tax -235-462 -255 235 299 345 835 1,108 Deferred Tax 0 0 0-251 -24 0 0 0 Tax Rate (%) 28.3 36.1 236.7-6.5 65.8 20.0 25.0 25.0 Reported PAT -595-817 147 253 143 1,381 2,504 3,324 PAT Adj for EO items -607-1,673 996 295 137 1,381 2,504 3,324 Change (%) 115.3 175.7 L/P -70.4-53.4 905.1 81.3 32.7 Margin (%) -1.3-3.4 1.8 0.6 0.3 2.7 4.6 6.0 Balance Sheet (INR Million) Y/E March 2013 2014 2015 2016 2017 2018E 2019E 2020E Equity Share Capital 5,034 5,034 5,034 5,034 5,034 5,034 5,034 5,034 Total Reserves 5,864 5,047 4,658 4,371 4,523 5,610 7,819 10,848 Net Worth 10,897 10,081 9,691 9,405 9,557 10,643 12,853 15,882 Deferred Liabilities 919 452 136 0 0 0 0 0 Total Loans 16,084 18,333 18,828 18,524 16,308 16,308 14,308 9,308 Capital Employed 27,900 28,866 28,655 27,929 25,864 26,951 27,161 25,190 Gross Block 31,984 34,553 35,418 22,526 23,585 25,731 27,231 29,231 Less: Accum. Deprn. 11,890 13,607 14,935 2,092 3,693 5,173 6,815 8,527 Net Fixed Assets 20,094 20,946 20,483 20,433 19,892 20,558 20,416 20,704 Capital WIP 839 626 688 683 945 300 300 300 Total Investments 3,782 3,473 3,378 3,296 3,819 3,819 3,819 3,819 Curr. Assets, Loans&Adv. 14,983 14,083 15,744 15,752 12,698 11,435 11,498 8,576 Inventory 4,674 4,622 5,500 4,717 3,997 4,747 4,919 4,637 Account Receivables 4,779 5,258 5,574 6,087 6,055 5,063 4,919 4,803 Cash and Bank Balance 375 525 797 1,152 667-1,540-1,454-3,844 Loans and Advances 5,155 3,679 3,873 3,797 1,979 3,165 3,115 2,981 Curr. Liability & Prov. 12,599 12,535 14,113 15,000 15,039 12,710 12,422 11,759 Account Payables 12,164 12,130 13,648 14,285 14,518 12,659 12,297 11,592 Provisions 434 405 465 715 521 52 125 166 Net Current Assets 2,384 1,548 1,631 752-2,342-1,275-924 -3,183 Appl. of Funds 27,900 28,866 28,655 27,929 25,864 26,951 27,161 25,190 E: MOSL Estimates 4 December 2017 7

Financials and Valuations Ratios Y/E March 2013 2014 2015 2016 2017 2018E 2019E 2020E Basic (INR) EPS -1.2-3.3 2.0 0.6 0.3 2.7 5.0 6.6 Cash EPS 2.0 0.2 4.7 4.2 4.1 5.7 8.2 10.0 BV/Share 21.6 20.0 19.3 18.7 19.0 21.1 25.5 31.6 DPS 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 Payout (%) 0.0 0.0 0.0 0.0 0.0 21.3 11.8 8.9 Valuation (x) P/E 193.8 415.4 41.3 22.8 17.2 Cash P/E 26.7 27.8 20.0 13.8 11.3 P/BV 6.1 6.0 5.4 4.4 3.6 EV/Sales 1.4 1.4 1.4 1.3 1.3 EV/EBITDA 25.8 23.5 20.1 13.4 10.8 EV/Ton (US$) 148.3 159.4 158 103 152 Dividend Yield (%) 0.0 0.0 0.4 0.4 0.4 Return Ratios (%) RoIC 2.4-1.5-7.1 4.7 1.8 8.0 11.5 14.5 RoE -5.4-15.9 10.1 3.1 1.4 13.7 21.3 23.1 RoCE 3.0-0.5-8.7 11.7 3.3 10.6 14.0 17.5 Working Capital Ratios Asset Turnover (x) 1.8 1.7 1.9 1.8 1.8 2.0 2.0 2.1 Inventory (Days) 37.0 34.8 38.2 32.1 28.8 34.1 33.6 30.6 Debtor (Days) 35.1 36.7 35.8 37.9 39.4 32.7 30.5 29.1 Leverage Ratio (x) Current Ratio 1.2 1.1 1.1 1.1 0.8 0.9 0.9 0.7 Debt/Equity 1.5 1.8 1.9 2.0 1.7 1.5 1.1 0.6 Cash Flow Statement (INR Million) Y/E March 2013 2014 2015 2016 2017 2018E 2019E 2020E Oper. P/L before Tax 744-567 1,252 1,021 1,131 2,238 3,759 4,792 Interest/Dividends Recd. 313 363 556 2,070 1,437 1,250 1,300 1,300 Depreciation 1,598 1,766 1,368 1,841 1,918 1,479 1,642 1,712 Direct Taxes Paid -2-5 -62-483 -551-345 -835-1,108 (Inc)/Dec in WC -2,275 987 190 1,233 2,609-3,273-266 -131 CF from Operations 377 2,543 3,304 5,682 6,544 1,349 5,600 6,564 EO expense -24-133 316-234 -359 0 0 0 CF from Operating incl EO 353 2,410 3,620 5,448 6,185 1,349 5,600 6,564 (inc)/dec in FA -2,697-2,356-927 12,898-1,322-1,500-1,500-2,000 Free Cash Flow -2,344 54 2,693 18,345 4,863-151 4,100 4,564 (Pur)/Sale of Investments 118 310 95 82-524 0 0 0 CF from investments -2,579-2,046-832 12,980-1,846-1,500-1,500-2,000 Issue of Shares 7 0-536 -539 9 0 0 0 (Inc)/Dec in Debt 3,401 2,249 494-304 -2,216 0-2,000-5,000 Interest Paid -1,903-2,415-2,536-2,814-2,166-1,761-1,720-1,660 Dividend Paid 0 0 0 0 0-294 -294-294 CF from Fin. Activity 1,504-166 -2,578-3,657-4,373-2,056-4,014-6,954 Inc/Dec of Cash -191 198 209 14,771-33 -2,207 86-2,390 Add: Beginning Balance 565 375 525 797 1,152 667-1,540-1,454 Closing Balance 374 525 693 15,568 1,119-1,540-1,454-3,844 E: MOSL Estimates 4 December 2017 8

N O T E S 4 December 2017 9

Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations). Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. Prism (MOFSL). Cement MOFSL is a listed public company, the details in respect of which are available on www.motilaloswal.com. MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited (BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association of Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at http://onlinereports.motilaloswal.com/dormant/documents/associate%20details.pdf Pending Regulatory Enquiries against Motilal Oswal Securities Limited by SEBI: SEBI pursuant to a complaint from client Shri C.R. Mohanraj alleging unauthorized trading, issued a letter dated 29th April 2014 to MOSL notifying appointment of an Adjudicating Officer as per SEBI regulations to hold inquiry and adjudge violation of SEBI Regulations; MOSL requested SEBI to provide all documents, records, investigation report relied upon by SEBI which were referred in Show Cause Notice. The matter is currently pending. MOSL, it s associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at the end of the month immediately preceding the date of publication of the Research Report. MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have received any compensation from the subject company in the past 12 months. In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have: a) managed or co-managed public offering of securities from subject company of this research report, b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report, c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report. d) Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report. MOSL and it s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Terms & Conditions: This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by virtue of their receiving this report. Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. Disclosure of Interest Statement Prism Cement Analyst ownership of the stock No A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or its associates maintains arm s length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have expressed their views. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL & its group companies to registration or licensing requirements within such jurisdictions. For Hong Kong: This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) SFO. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to Professional Investors as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be engaged only with professional investors. Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Disclaimer: The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval. MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id: na@motilaloswal.com, Contact No.:022-30801085. Registration details of group entities.: MOSL: SEBI Registration: INZ000158836 (BSE/NSE/MSE); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA000007100. Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products 4 December 2017 10